Data

A randomised trial of idarubicin dose escalation in consolidation therapy following intensive induction chemotherapy incorporating high dose cytarabine in patients with untreated adult acute myeloid leukaemia, to evaluate safety and improve remission rate.(AMLM12)

Health Data Australia Contributor Records
Bradstock, Kenneth ; Australasian Leukaemia And Lymphoma Group (ALLG) ; Australasian Leukaemia And Lymphoma Group (ALLG)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.58109/GFYK-K522&rft.title=A randomised trial of idarubicin dose escalation in consolidation therapy following intensive induction chemotherapy incorporating high dose cytarabine in patients with untreated adult acute myeloid leukaemia, to evaluate safety and improve remission rate.(AMLM12)&rft.identifier=http://doi.org/10.58109/GFYK-K522&rft.publisher=Australasian Leukaemia and Lymphoma Group (ALLG)&rft.description=Dataset includes: Data for 42 patients Includes first Australian study conducted in AML using dose escalation therapy. Also investigates use of antiemetics and oral mucositis medication Demographic data, diagnostic data, treatment data, outcome data induction and consolidation treatment, including measurements for progression and clinical outcomes. Patients who underwent BMT were censored for this study&rft.creator=Bradstock, Kenneth &rft.creator=Australasian Leukaemia And Lymphoma Group (ALLG) &rft.creator=Australasian Leukaemia And Lymphoma Group (ALLG) &rft.date=2023&rft.relation=https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12605000095662&rft_subject=Chemotherapy&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Full description

Dataset includes: Data for 42 patients Includes first Australian study conducted in AML using dose escalation therapy. Also investigates use of antiemetics and oral mucositis medication Demographic data, diagnostic data, treatment data, outcome data induction and consolidation treatment, including measurements for progression and clinical outcomes. Patients who underwent BMT were censored for this study

Notes

HeSANDA 1.0.0

Issued: 2023

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related Publications

Related Organisations

Subjects
Chemotherapy |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information
A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia

doi : http://doi.org/10.1111/bjh.13086

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia

doi : https://doi.org/10.1200/JCO.2016.70.6374

Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapy

doi : http://doi.org/10.1111/bjh.12178

Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies

doi : http://doi.org/10.1038/s41408-018-0121-4

Australasian Leukaemia And Lymphoma Group (ALLG)

ROR : https://ror.org/05t72y326

Australasian Leukaemia and Lymphoma Group (ALLG)

ROR : https://ror.org/05t72y326

Identifiers
Similar data you may be interested in: